Re: Brandt et al.--An evidence-based approach to the management of irritable bowel syndrome in North America

Am J Gastroenterol. 2003 Sep;98(9):2105-6. doi: 10.1111/j.1572-0241.2003.07654.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Carbolines / adverse effects*
  • Carbolines / therapeutic use
  • Clinical Trials as Topic
  • Colitis, Ischemic / chemically induced*
  • Colitis, Ischemic / epidemiology
  • Colonic Diseases, Functional / diagnosis
  • Colonic Diseases, Functional / drug therapy*
  • Constipation / chemically induced*
  • Constipation / epidemiology
  • Evidence-Based Medicine
  • Female
  • Humans
  • Male
  • North America
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Carbolines
  • alosetron